Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

JOURNAL ARTICLE

Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial"

Walter C Willett, JoAnn E Manson, Francine Grodstein, Meir J Stampfer, Graham A Colditz

American Journal of Epidemiology 2006 June 1, 163 (11): 1067-8; author reply 1068-9

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Ross L Prentice, Robert Langer, Marcia L Stefanick, Barbara V Howard, Mary Pettinger, Garnet Anderson, David Barad, J David Curb, Jane Kotchen, Lewis Kuller, Marian Limacher, Jean Wactawski-Wende et al. American Journal of Epidemiology 2005 September 1, 162 (5): 404-14

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Ross L Prentice, Robert D Langer, Marcia L Stefanick, Barbara V Howard, Mary Pettinger, Garnet L Anderson, David Barad, J David Curb, Jane Kotchen, Lewis Kuller, Marian Limacher, Jean Wactawski-Wende et al. American Journal of Epidemiology 2006 April 1, 163 (7): 589-99

Invited commentary: how far can epidemiologists get with statistical adjustment? Diana B Petitti, David A Freedman American Journal of Epidemiology 2005 September 1, 162 (5): 415-8; discussion 419-20

Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies. S Shapiro Climacteric: the Journal of the International Menopause Society 2006, 9 (6): 416-20

Postmenopausal hormone replacement therapy in the light of the women's health initiative trial. M J van der Mooren, P Kenemans European Journal of Obstetrics, Gynecology, and Reproductive Biology 2003 April 25, 107 (2): 123-4

The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice. Susan L Hendrix Journal of the American Osteopathic Association 2003, 103 (2): S3-5

The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results. Herbert Kuhl, John Stevenson Gynecological Endocrinology 2006, 22 (6): 303-17

Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative. Andrew M Kaunitz et al. Medscape Women's Health 2002, 7 (4): 8

Lung cancer and hormone replacement therapy. Marianne Canonico, Geneviève Plu-Bureau, Pierre-Yves Scarabin Lancet 2010 January 9, 375 (9709): 117; author reply 118-9

Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over. (no author information available yet) Harvard Women's Health Watch 2002, 10 (2): 2-4

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Re: "combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the women's health initiative clinical trial"

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips